These models are not mutually exclusive, and further work will define their relative contributions to the pathology of XLRP, as well as addressing the important translational implication of our study that pharmacomodulation or ectopic expression of activated gelsolin in the retina could slow or reverse the retinal degeneration observed in RPGR/XLRP disease. This evidence concerns the gene GSN and retinal degeneration.